Actionnariat et activité des initiés pour Eledon Pharmaceuticals, Inc. (ELDN): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $2.67 |
| Capitalisation | $206M |
| Bourse | NASDAQ |
| Pays | US |
Transactions d'Initiés Récentes
| Date | Initié | Type | Actions | Valeur |
|---|---|---|---|---|
| 2026-07-31 | Gros David-Alexandre C | A-Award | 354,454 | |
| 2026-07-31 | Gros David-Alexandre C | F-InKind | 194,791 | $658K |
| 2026-07-31 | Perrin Steven | A-Award | 152,353 | |
| 2026-07-31 | Perrin Steven | F-InKind | 72,138 | $244K |
| 2026-01-10 | McBride John S. | M-Exempt | 3,430 | |
| 2026-01-10 | McBride John S. | M-Exempt | 3,430 | |
| 2026-01-10 | Hillson Jan | M-Exempt | 3,430 | |
| 2026-01-10 | Hillson Jan | M-Exempt | 3,430 | |
| 2026-01-10 | Kirk Allan | M-Exempt | 3,430 | |
| 2026-01-10 | Kirk Allan | M-Exempt | 3,430 |
Bilan (10 ans)
| Année | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Trésorerie | $23.2M | $17.2M | $13.0M | $8.8M | $114.2M | $84.8M | $56.4M | $4.6M | $20.5M | $22.8M |
| Placements à Court Terme | $4.2M | 0 | 0 | 0 | 0 | 0 | 0 | $46.5M | $119.6M | $110.5M |
| Créances | 0 | 0 | $594000 | $245000 | $110000 | 0 | 0 | 0 | 0 | $514000 |
| Stocks | 0 | 0 | 0 | $881000 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Courants | $29.5M | $19.0M | $14.3M | $10.0M | $115.6M | $88.3M | $59.5M | $56.1M | $143.7M | $135.7M |
| Immobilisations Corporelles | $98000 | $25000 | $14000 | $321000 | $138000 | $768000 | $739000 | $365000 | $926000 | $613000 |
| Goodwill | 0 | $1.9M | $1.9M | 0 | $48.6M | $48.6M | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | 0 | 0 | 0 | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M | $32.4M |
| Actifs Totaux | $29.8M | $20.9M | $17.0M | $10.9M | $197.2M | $170.5M | $92.8M | $89.1M | $177.4M | $169.0M |
| Dettes Fournisseurs | $338000 | $418000 | $689000 | $329000 | $1.4M | $1.8M | $2.2M | $967000 | $5.8M | $3.6M |
| Dette à Court Terme | $3.4M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Courants | $2.8M | $1.4M | $2.5M | $1.3M | $2.5M | $4.4M | $6.5M | $3.9M | $11.6M | $18.3M |
| Dette à Long Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Passifs Totaux | $2.9M | $1.4M | $2.5M | $1.5M | $6.6M | $6.6M | $8.6M | $81.9M | $59.3M | $87.9M |
| Réserves | -$169.4M | -$27.5M | -$41.6M | -$57.6M | -$80.4M | -$114.9M | -$202.9M | -$319.4M | -$355.6M | -$401.2M |
| Capitaux Propres | $26.9M | $19.5M | $14.5M | $9.5M | $190.6M | $164.0M | $84.2M | $7.2M | $118.1M | $81.1M |
| Dette Totale | $3.4M | 0 | 0 | $324000 | $144000 | $769000 | $746000 | $383000 | $954000 | $641000 |
| Dette Nette | -$24.0M | -$17.2M | -$13.0M | -$8.5M | -$114.1M | -$84.1M | -$55.7M | -$50.7M | -$139.2M | -$132.7M |
| Fonds de Roulement | $26.7M | $17.6M | $11.7M | $8.6M | $113.1M | $83.9M | $53.0M | $52.2M | $132.2M | $117.3M |
Santé financière
| Dette / Capitaux propres | 0.01 |
| Ratio de liquidité | 7.90 |
Rentabilité
| Rentabilité des capitaux propres | -136.45% |
| Rentabilité du capital investi | -73.77% |
| Rentabilité des actifs | -78.16% |
| Marge brute | 0.00% |
| Marge opérationnelle | 0.00% |
| Marge nette | 0.00% |
Entreprises liées: ABEO · ACHV · ALLO · AVIR · EDIT · HUMA · PBYI
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ELDN: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions